Reproductive Endocrinology Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Reproductive Endocrinology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Reproductive Endocrinology Indian Medical PG Question 1: Testicular feminization syndrome is characterized by all of the following except?
- A. Absent uterus
- B. Primary amenorrhea
- C. Normal breast development
- D. Presence of Barr body (Correct Answer)
Reproductive Endocrinology Explanation: **Explanation:**
**Testicular Feminization Syndrome (now known as Complete Androgen Insensitivity Syndrome - CAIS)** is a condition where a genetic male (46, XY) has a total resistance to androgens due to a defect in the androgen receptor.
**Why Option D is the Correct Answer:**
The **Barr body** represents an inactivated X chromosome, typically found in individuals with more than one X chromosome (e.g., 46, XX females or 47, XXY males). Since CAIS patients have a **46, XY genotype**, they possess only one X chromosome, which remains active. Therefore, they are **Barr body negative**.
**Analysis of Other Options:**
* **A. Absent uterus:** In these patients, the testes are present (usually intra-abdominal) and secrete **Anti-Müllerian Hormone (AMH)**. AMH causes the regression of Müllerian structures, leading to the absence of the uterus, fallopian tubes, and upper third of the vagina.
* **B. Primary amenorrhea:** Due to the absence of a uterus and ovaries, these patients typically present during puberty with a failure to start menstruation.
* **C. Normal breast development:** Peripheral conversion of testosterone to estrogen (aromatization) occurs. Since there is no androgen action to oppose this estrogen, patients develop normal, often feminine, breast contours (though the nipples/areolae may be pale).
**High-Yield Clinical Pearls for NEET-PG:**
* **Karyotype:** 46, XY (Genetically male, Phenotypically female).
* **Gonads:** Testes (Risk of gonadoblastoma; gonadectomy is recommended after puberty/attainment of height).
* **Hair:** Characteristically **absent or scanty** axillary and pubic hair (due to androgen resistance).
* **Vagina:** Blind-ending pouch (short vagina).
* **Differential Diagnosis:** **Müllerian Agenesis (MRKH Syndrome)**. Distinguishing factor: MRKH has a 46, XX karyotype, normal pubic hair, and normal ovaries.
Reproductive Endocrinology Indian Medical PG Question 2: A female presents with normal breast development but scanty pubic hair. What is the most likely diagnosis?
- A. Turner's syndrome
- B. Testicular feminizing syndrome (Correct Answer)
- C. Mullerian agenesis
- D. Gonadal dysgenesis
Reproductive Endocrinology Explanation: **Explanation:**
The clinical presentation of **normal breast development** paired with **scanty or absent pubic/axillary hair** is a classic hallmark of **Androgen Insensitivity Syndrome (AIS)**, historically known as **Testicular Feminizing Syndrome**.
**1. Why the Correct Answer is Right:**
In AIS, the individual has a **46, XY** karyotype and functioning testes that produce testosterone. However, due to a defect in androgen receptors, the body cannot respond to testosterone.
* **Breast Development:** Occurs because the high levels of testosterone are peripherally converted to estrogen (aromatization).
* **Scanty Pubic Hair:** Pubic and axillary hair growth is dependent on androgens. Since the receptors are non-functional, hair growth is minimal or absent.
* **Anatomy:** MIF (Müllerian Inhibiting Factor) is produced, so there is no uterus or fallopian tubes (blind-ending vagina).
**2. Why Incorrect Options are Wrong:**
* **Turner’s Syndrome (45, XO):** Characterized by "streak gonads" and low estrogen. Patients typically present with **primary amenorrhea and absent breast development** (sexual infantilism).
* **Müllerian Agenesis (MRKH Syndrome):** These patients are **46, XX** with normal ovaries. They have **normal breast development AND normal pubic hair** (since androgen receptors are functional), but lack a uterus and upper vagina.
* **Gonadal Dysgenesis:** Similar to Turner’s, the lack of functional gonads leads to estrogen deficiency, resulting in a lack of secondary sexual characteristics (no breast development).
**High-Yield Clinical Pearls for NEET-PG:**
* **Karyotype:** AIS is 46, XY; MRKH is 46, XX.
* **Gonads:** In AIS, testes are often found in the inguinal canal or abdomen (risk of gonadoblastoma; requires removal after puberty).
* **Differential Diagnosis:** The presence or absence of pubic hair is the most important clinical differentiator between AIS (absent) and MRKH (present).
Reproductive Endocrinology Indian Medical PG Question 3: Which of the following tests can differentiate Mullerian agenesis (MRKH syndrome) from complete androgen insensitivity syndrome (testicular feminization syndrome)?
- A. 3D Ultrasound
- B. MRI
- C. Karyotyping (Correct Answer)
- D. Serum testosterone levels
Reproductive Endocrinology Explanation: **Explanation:**
Both **Mullerian Agenesis (MRKH Syndrome)** and **Complete Androgen Insensitivity Syndrome (CAIS)** present with primary amenorrhea, a blind vaginal pouch, and well-developed breasts. However, their underlying genetic and hormonal profiles are fundamentally different.
**Why Karyotyping is the Correct Answer:**
Karyotyping is the definitive diagnostic tool to differentiate these two conditions.
* **MRKH Syndrome:** Patients are genetically female (**46, XX**). They have normal ovaries and female-range testosterone levels.
* **CAIS:** Patients are genetically male (**46, XY**). They have undescended testes and male-range testosterone levels, but appear phenotypically female because their tissues are unresponsive to androgens.
**Analysis of Incorrect Options:**
* **A & B (3D Ultrasound/MRI):** While both imaging modalities are excellent for identifying the absence of a uterus and cervix, they cannot reliably distinguish between a 46,XX individual (MRKH) and a 46,XY individual (CAIS) based solely on pelvic anatomy, as both lack Mullerian structures.
* **D (Serum Testosterone):** While testosterone levels are significantly higher in CAIS (male range) than in MRKH (female range), **Karyotyping** remains the gold standard for definitive diagnosis and is the preferred initial step in the workup of primary amenorrhea with absent internal organs.
**High-Yield Clinical Pearls for NEET-PG:**
1. **Pubic/Axillary Hair:** This is the most important clinical differentiator. It is **normal** in MRKH but **absent or scanty** in CAIS (due to androgen resistance).
2. **Gonads:** In MRKH, ovaries are present (normal ovulation/hormones). In CAIS, testes are present (usually intra-abdominal or inguinal).
3. **Management:** In CAIS, the gonads must be removed (gonadectomy) after puberty to prevent malignancy (gonadoblastoma/dysgerminoma). In MRKH, the focus is on vaginal creation (dilatation or vaginoplasty).
Reproductive Endocrinology Indian Medical PG Question 4: A 20-year-old young woman presents with a history of rapidly developing hirsutism and amenorrhea with a change in voice. Which of the following blood tests would be most appropriate to establish a diagnosis?
- A. 17-hydroxyprogesterone
- B. Dehydroepiandrosterone (DHEA)
- C. Testosterone (Correct Answer)
- D. Luteinizing hormone (LH) + Follicle-stimulating hormone (FSH) estimation
Reproductive Endocrinology Explanation: **Explanation:**
The clinical presentation of **rapidly developing hirsutism**, **amenorrhea**, and **virilization** (deepening of voice) in a young woman is highly suggestive of an **androgen-secreting tumor** (ovarian or adrenal).
1. **Why Testosterone is the correct answer:**
In cases of rapid-onset virilization, the primary goal is to rule out a testosterone-secreting ovarian tumor (e.g., Sertoli-Leydig cell tumor). Serum **Total Testosterone** levels >200 ng/dL are a strong biochemical marker for such neoplasms. While PCOS causes gradual hirsutism, a sudden onset with virilization points toward malignancy or a functional tumor, making testosterone the most critical initial diagnostic test.
2. **Why other options are incorrect:**
* **17-hydroxyprogesterone:** This is the screening test for **Congenital Adrenal Hyperplasia (CAH)**. While CAH causes hirsutism, it is usually present from childhood/puberty and rarely presents with such a rapid, fulminant course in a 20-year-old.
* **DHEA/DHEA-S:** DHEA-S is a marker for **adrenal** sources of androgens. While it should be measured if an adrenal tumor is suspected (levels >700 µg/dL), Testosterone is generally the more sensitive first-line marker for overall virilization.
* **LH/FSH ratio:** This is used to support a diagnosis of **PCOS** (where the ratio is often >2:1). However, PCOS causes slow, progressive hirsutism and does not typically cause voice changes (virilization).
**Clinical Pearls for NEET-PG:**
* **Rapid onset + Virilization** = Think Androgen-secreting Tumor.
* **Gradual onset + Obesity + Irregular periods** = Think PCOS.
* **Testosterone >200 ng/dL:** Evaluate for Ovarian Tumor (e.g., Sertoli-Leydig).
* **DHEA-S >700 µg/dL:** Evaluate for Adrenal Tumor.
* **Deepening of voice and clitoromegaly** are signs of virilization, not just hirsutism, and always require urgent investigation to rule out malignancy.
Reproductive Endocrinology Indian Medical PG Question 5: A young female presented with primary amenorrhea. Examination reveals normal breast development and absent axillary hairs. Pelvic examination shows a normally developed vagina with clitoromegaly. On ultrasound, gonads are visible in the inguinal region. What is the most likely diagnosis?
- A. Complete androgen insensitivity syndrome
- B. Partial androgen insensitivity syndrome (Correct Answer)
- C. Mayer Rokitansky Kuster Hauser syndrome
- D. Gonadal dysgenesis
Reproductive Endocrinology Explanation: **Explanation:**
The clinical presentation hinges on the spectrum of **Androgen Insensitivity Syndrome (AIS)**, an X-linked recessive condition where a 46,XY individual has a functional defect in androgen receptors.
**Why Partial AIS (PAIS) is correct:**
In PAIS, there is partial responsiveness to androgens. The presence of **clitoromegaly** (ambiguous genitalia) and **axillary hair** (though often sparse, its presence or the virilization of genitalia distinguishes it from the "Complete" form) are hallmark signs. The patient has normal breast development due to the peripheral conversion of testosterone to estrogen. The presence of **inguinal gonads** (testes) and a short/blind-ending vagina (due to Anti-Müllerian Hormone production by testes) confirms the diagnosis.
**Why other options are incorrect:**
* **Complete AIS (CAIS):** Presents with a purely female phenotype. There is **no clitoromegaly** and characteristically **absent or very scanty** axillary/pubic hair.
* **MRKH Syndrome:** These are 46,XX individuals with normal ovaries. They would have **normal axillary/pubic hair** (normal adrenarche) and no clitoromegaly or inguinal testes.
* **Gonadal Dysgenesis (e.g., Turner Syndrome):** Typically presents with **absent breast development** (due to ovarian failure/streak gonads) and elevated gonadotropins.
**High-Yield Clinical Pearls for NEET-PG:**
* **Karyotype:** Both CAIS and PAIS are **46,XY**.
* **The "Hair" Rule:** CAIS = Hairless (absent axillary/pubic hair); MRKH = Hairy (normal hair).
* **Management:** In AIS, gonads are removed after puberty (to allow natural height gain and breast development) to prevent **gonadoblastoma/dysgerminoma**, followed by estrogen replacement.
* **Differential:** If a patient has primary amenorrhea, absent uterus, but **normal male-range testosterone**, think AIS. If testosterone is in the **female range**, think MRKH.
More Reproductive Endocrinology Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
